Assessing the costs and efficiency of HIV testing and treatment services in rural Malawi: implications for future “test and start” strategies
Seema VyasJohn SongoLorna GuinnessAlbert DubeSteffen GeisThokozani KaluaJim ToddJenny RenjuAmelia C. CrampinAlison Wringe
11
Citation
25
Reference
10
Related Paper
Citation Trend
Abstract:
Abstract Background Reaching the 90–90-90 targets requires efficient resource use to deliver HIV testing and treatment services. We investigated the costs and efficiency of HIV services in relation to HIV testing yield in rural Karonga District, Malawi. Methods Costs of HIV services were measured over 12 months to September 2017 in five health facilities, drawing on recognised health costing principles. Financial and economic costs were collected in Malawi Kwacha and United States Dollars (US$). Costs were calculated using a provider perspective to estimate average annual costs (2017 US$) per HIV testing episode, per HIV-positive case diagnosed, and per patient-year on antiretroviral therapy (ART), by facility. Costs were assessed in relation to scale of operation and facility-level annual HIV positivity rate. A one-way sensitivity analysis was undertaken to understand how staffing levels and the HIV positivity rate affected HIV testing costs. Results HIV testing episodes per day and per full-time equivalent HIV health worker averaged 3.3 (range 2.0 to 5.7). The HIV positivity rate averaged 2.4% (range 1.9 to 3.7%). The average cost per testing episode was US$2.85 (range US$1.95 to US$8.55), and the average cost per HIV diagnosis was US$116.35 (range US$77.42 to US$234.11), with the highest costs found in facilities with the lowest daily number of tests and lowest HIV yield respectively. The mean facility-level cost per patient-year on ART was approximately US$100 (range US$90.67 to US$115.42). ART drugs were the largest cost component averaging 71% (range 55 to 76%). The cost per patient-year of viral load tests averaged US$4.50 (range US$0.52 to US$7.00) with cost variation reflecting differences in the tests to ART patient ratio across facilities. Conclusion Greater efficiencies in HIV service delivery are possible in Karonga through increasing daily testing episodes among existing health workers or allocating health workers to tasks in addition to testing. Costs per diagnosis will increase as yields decline, and therefore, encouraging targeted testing strategies that increase yield will be more efficient. Given the contribution of drug costs to per patient-year treatment costs, it is critical to preserve the life-span of first-line ART regimens, underlining the need for continuing adherence support and regular viral load monitoring.Keywords:
Staffing
Health administration
Health Economics
Average cost
Health administration
Health Economics
Health Services Research
Cite
Citations (16)
Health administration
Health Economics
Health care management
Health Services Research
Cite
Citations (8)
This article analyzes the cost and income of application of activity-based costing by the economic way.Then the total-cost chart of application of activity-based costing in short-term and the long-term separately.Comporting total-cost with the best total-cost,we propose that the activity-based costing may and must be promoted in our country.
Cost driver
Job costing
Total absorption costing
Cite
Citations (0)
Health administration
Health Economics
Health Services Research
Cite
Citations (0)
Health Economics
Health administration
Health Services Research
Cite
Citations (13)
Health administration
Health Economics
Health Services Research
Health care management
Cite
Citations (4)
This paper presents an analysis of existing costing system in a rubberised coir mattress company. After identifying inherent problems in the system an alternative costing model based on Activity Based Costing is developed. Actual cost data for a period of one month is used for cost allocation and arriving at unit cost of cost objects consumed by various products. Production cost of a particular model is obtained based on the actual usage of cost objects as per the specification for the model. Production cost of three selected models from different segments is calculated using the new model and compared with that of existing model. The new costing system revealed that production cost for the selected models are 18%, 19% and 34% lower than the existing cost accounted. A cumulative reduction of 3.07 Cr in annual production cost is accounted for the three models.
Total absorption costing
Cost driver
Production cost
Unit cost
Process costing
Cost reduction
Cost allocation
Cost database
Cite
Citations (0)
Health administration
Biopharmaceutical
Health Economics
Health care management
Pharmacoeconomics
Cite
Citations (11)
Economic evaluation of a leprosy innovation project in Northern Nigeria: cost-effectiveness analysis
The state of leprosy in Nigeria and the realities of post elimination era underscore the need for evidence- based cost-effective approach to early case detection for enhanced control and elimination of leprosy. This study evaluated the operational cost-effectiveness of a community delivered Legacy Innovative Project implemented to enhance leprosy case detection in northern Nigeria.Data were collected from an explorative cross-sectional study, undertaken in a practice setting among endemic communities in three states in northern Nigeria. Primary and secondary data were collected from the project, routine records and programme annual reports. Costs and effects were measured from both providers' and patients' perspectives, and outcome expressed as cost per new case detected. Incremental estimates of costs and effects of the project compared to routine practice were used to obtain the cost-effectiveness result, as incremental cost-effectiveness ratio (ICER). All costs were converted to the US Dollar at 2018exchange rate (N350 = US$1.00). Univariate sensitivity analysis was performed to evaluate uncertainties around the ICER.The Project overall detected a total of 347 newly confirmed leprosy cases at a total annual cost of US$49,337.19, averaging US$142.18 per new case detected. Key cost drivers included routine meetings, which accounted for 28% of total expenditure, while Social Mobilization and Training/Workshop accounted for17% respectively. Findings were similar across the states. Overall, the Project dominated routine practice with ICER of US$(-17.73) per additional/new case detected, as a very cost-effective strategy. Sensitivity analysis reinforced the cost-effectiveness result.The Legacy Innovative Project demonstrated a more efficient and cost-saving approach to leprosy case detection. Findings present important information to policy and programmes for enhanced control and elimination of leprosy in related settings. .
Health administration
Health Economics
Health Services Research
Cite
Citations (0)
Health Economics
Health administration
Excellence
Health Services Research
Health care management
Cite
Citations (0)